NPR News·3 min read·medium

U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech

B
Brittney Melton
U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
AI Summary

The U.S. military is facing a depletion of long-range precision missiles due to ongoing conflicts, raising concerns about future readiness and the ability to support allies like Ukraine. Separately, the FDA is evaluating the use of mRNA technology for upcoming flu vaccines.

Good morning. You're reading the Up First newsletter. Subscribe here to get it delivered to your inbox, and listen to the Up First podcast for all the news you need to start your day.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
politicssciencehealth

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in